Related Experiment Videos
The incidence of diuretic-induced hypokalemia in two distinct clinic settings
Insights
Diuretic-induced hypokalemia (DIH) occurred more frequently in hypertensive patients with lower baseline potassium levels, particularly Black females, despite similar blood pressure control.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Hypertension management often involves diuretics, which can lead to electrolyte imbalances like hypokalemia.
- Diuretic-induced hypokalemia (DIH) is a known side effect, but its incidence can vary based on patient population and treatment setting.
- Understanding risk factors for DIH is crucial for optimizing patient safety and treatment efficacy.
Purpose of the Study:
- To investigate the incidence of DIH in two distinct hypertensive populations treated with hydrochlorothiazide (HCTZ).
- To identify potential demographic or clinical factors associated with a higher risk of DIH.
Main Methods:
- A comparative study involving 37 patients with mild hypertension treated with HCTZ over 6 months.
- Two groups were analyzed: Group 1 (25 mg HCTZ q.d. in a public clinic) and Group 2 (50 mg HCTZ q.d. in a private practice).
- Demographic data, baseline serum potassium, and incidence of DIH (serum potassium < 3.5 mEq/L) were recorded and compared.
Main Results:
- Group 1, predominantly nonwhite with lower baseline serum potassium, showed a significantly higher incidence of DIH (52%) compared to Group 2 (19%).
- Despite equivalent blood pressure reductions, Group 1 experienced more DIH, suggesting baseline potassium levels are a key factor.
- Black females were identified as a subgroup particularly at risk for developing DIH.
Conclusions:
- Lower baseline serum potassium levels are a significant predictor of DIH in hypertensive patients treated with HCTZ.
- Treatment setting and patient demographics, including race and sex, influence DIH incidence.
- Clinical monitoring of serum potassium is essential, especially in at-risk populations, to prevent DIH during diuretic therapy.
Abstract:
We studied the incidence of diuretic-induced hypokalemia (DIH) in two diuretic-treated hypertensive populations. Thirty-seven patients with mild hypertension were treated with HCTZ and monitored over 6 months. Group 1 (21 patients) was treated with 25 mg HCTZ q.d. in a public hypertension clinic. Group 2 (16 patients) was treated with 50 mg HCTZ q.d. in a private-practice setting. Group 1 was predominantly nonwhite (76% vs. 31% [p less than 0.002]). Baseline serum potassium levels were lower in group 1 (3.93 vs. 4.42 mEq/L [p less than 0.001]). Equivalent reductions in blood pressure and serum potassium were observed in both groups. Contrary to expectations, DIH (serum potassium less than 3.5 mEq/L) developed in 52% of group 1 and 19% of group 2 (p = 0.037). Black females were especially at risk for DIH. The higher incidence of DIH in group 1 appears to be related to lower baseline serum potassium levels.